1 / 17

Farren et al Supplementary Table1.

Farren et al Supplementary Table1. 1. 6. 9. 5. 7. 8. 5. 0. u. o. 5. v. 1. 9. 6. 7. 3. 9. A. 3. M. -. -. -. c. 1. 2. 0. 6. 4. 2. F. 7. 5. 3. 4. 8. D. V. R. S. 5. u. C. C. 1. T. 2. 4. 6. 3. 7. 4. 5. C. N. -. o. 4. a. l. N. 7. A. -. P.

nash
Télécharger la présentation

Farren et al Supplementary Table1.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Farren et al Supplementary Table1.

  2. 1 6 9 5 7 8 5 0 u o 5 v 1 9 6 7 3 9 A 3 M - - - c 1 2 0 6 4 2 F 7 5 3 4 8 D V R S 5 u C C 1 T 2 4 6 3 7 4 5 C N - o 4 a l N 7 A - P P o 3 S w A A A a H 7 F L T 3 I B M C l K A C E C 4 S o A C V - M M N M C H T - O A B D M a b 100 % 90 % 80 % 70 % 60 % % Human: Mouse mRNA 50 % 40 % 30 % 20 % G 10 % M - 7 8 U 0 % Human Proportion Mouse Proportion Farren et al Supplementary Figure 1

  3. Farren et al Supplementary Figure 2

  4. Low α-SMA staining <5% i U87MG ii LoVo iii A375M M I M iv A431 v Calu-6 vi HCT116 I M I Medium α-SMA staining 5% to 15% vii FaDu viii SW620 Iix BT474cl x HT29 E I E I xi PC9 xii Colo205 xiii A375 I E M High α-SMA staining >15% xiv A549 xv NCIN87 xvi MCF7 xvii PC3 I E E I Farren et al Supplementary Figure 3

  5. Farren et al Supplementary Table 2; Linear regression analysis of the quantified histological staining for α-SMA, F4/80 and MVD.

  6. Farren et al Supplementary Figure 4

  7. Tumour PCA Scores Plot Normalised to total 18s PC-2 PC-1 Farren et al Supplementary Figure 5

  8. A. PCA analysis of human cell line transcript profile B. PCA analysis of human xenograft transcript profile Farren et al Supplementary Figure 6.

  9. Farren et al Supplementary Table 3

  10. Farren et al Supplementary Table 4

  11. VEGF (-∆CT) ANGPT-1 (-∆CT) P Value = <0.001 R2 = 0.50 P Value = 0.004 R2 = 0.36 VEGF (log pg/ml) ANGPT-1 (log pg/ml) ANGPT-2 (-∆CT) FGF-2 (-∆CT) P Value = <0.001 R2 = 0.61 P Value = <0.001 R2 = 0.91 ANGPT-2 (log pg/ml) FGF-2 (log pg/ml) IL-8 (-∆CT) PGF (-∆CT) P Value = <0.001 R2 = 0.73 P Value = <0.001 R2 = 0.71 IL-8 (log pg/ml) PGF (log pg/ml) LoVo A375 MCF7 A375M MDA-MB-468 A375v Xenografts MES-SA A431 MKN 45 A549 NCI-N87 BT-474-c1 OVCAR 3 Calu-6 PC-3 Colo-205 PC-9 FaDu Sw620 HCT 116 U87-MG HT29 Farren et al Supplementary Figure 7

  12. Farren et al Supplementary Table 5:

  13. Farren et al Supplementary Table 6.

  14. Farren et al Supplementary Table 7.

  15. A Stromal PCA Scores Plot Normalised to total 18s PC-2 PC-1 B Stromal PCA Loading Plot Normalised to total 18s PC-2 PC-1 Farren et al Supplementary Figure 8

  16. Farren et al Supplementary Table 8:

  17. Farren et al Supplementary Figure 9

More Related